基本信息
浏览量:121
职业迁徙
个人简介
Dr. Dholaria's clinical interests include non-Hodgkin lymphoma, multiple myeloma, acute and chronic leukemias, adoptive cellular therapy (CAR-T), and stem cell transplantation. He is board certified in Internal Medicine, Hematology and Oncology. His primary field of research is in the use of adoptive cellular therapies for the treatment of relapsed lymphoid and plasma cell malignancies. He has conducted studies investigating the outcomes of non-Hodgkin lymphoma patients undergoing chimeric antigen receptor T-cell (CAR-T) therapies. He is involved in translational research investigating the biomarkers of CAR T-cell therapy associated toxicities. He has also conducted several observational studies utilizing cancer registries to study the outcomes of leukemia and lymphoma patients undergoing allogenic stem cell transplantation and presented his findings in national meetings.
研究兴趣
论文共 206 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Transplantation and Cellular Therapy (2024)
Johnathan Fraebel,Silvia Park, Rahul Shah, Carlos Prieto-Granada,Emily F. Mason,Salyka Sengsayadeth,Wichai Chinratanalab,Bipin Savani, Reena V. Jayani,Adetola Kassim,Bhagirathbhai R. Dholaria,Tae Kon Kim
Bone Marrow Transplantationpp.1-4, (2024)
Bone Marrow Transplantationno. 2 (2024): 211-216
Bloodno. 2 (2024): S14-S15
Blood Cancer Journalno. 1 (2024): 1-8
Bhagirathbhai Dholaria,Leyla Shune, Andrew Kin,Katherine McArthur, Jeff D. Eskew, Christopher E. Martin, Sabrina Haag,Joanne McCaigue,Hamid Namini, Sam DePrimo,Stacey Cranert,Julia Coronella,
Cancer Researchno. 7_Supplement (2024)
Bloodno. 2 (2024): S196-S198
Transplantation and Cellular Therapyno. 2 (2024): S57
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn